Is Edwards Lifesciences Stock Outperforming the S&P 500?

Valued at a market cap of $47.4 billion, Edwards Lifesciences Corporation (EW) is an Irvine, California-based company that provides products and technologies to treat advanced cardiovascular diseases. 

Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and EW fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical devices industry. The company recently divested its critical care unit, allowing it to sharpen its focus on high-growth areas like asymptomatic aortic stenosis and structural heart failure.